Gene Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Gene Symbol FOXL2
Synonyms BPES | BPES1 | PFRK | PINTO | POF3
Gene Description FOXL2, forkhead box L2, encodes for a transcription factor that is a member of the forked-winged helix family and plays a role in ovary development (PMID: 21640373). FOXL2 is commonly mutated in granulosa-cell tumors (PMID: 19956657).

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Variant Impact Protein Effect Variant Description Associated with drug Resistance
A253fs frameshift loss of function - predicted FOXL2 A253fs results in a change in the amino acid sequence of the Foxl2 protein beginning at aa 253 of 376, likely resulting in premature truncation of the functional protein (UniProt.org). A253fs results in impaired transactivation capacity of Foxl2 protein in culture (PMID: 19515849).
A331V missense unknown FOXL2 A331V does not lie within any known functional domains of the Foxl2 protein (UniProt.org). A331V has not been characterized and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
A66V missense loss of function FOXL2 A66V lies within the DNA binding region of the Foxl2 protein (UniProt.org). A66V results in Foxl2 protein aggregation and impaired ability to transactivate target genes in culture (PMID: 18372316).
amp none no effect FOXL2 amplification indicates an increased number of copies of the FOXL2 gene. However, the mechanism causing the increase is unspecified.
C134W missense gain of function FOXL2 C134W lies within the DNA binding domain of the Foxl2 protein (UniProt.org). C134W alters Foxl2 transcriptional regulation, resulting in the increased production of the target gene CYP19A1 (aromatase) (PMID: 21188138) and induces proliferation of ovarian granulosa cells (PMID: 28276867).
E118K missense unknown FOXL2 E118K lies within the DNA binding region of the Foxl2 protein (UniProt.org). E118K has been identified in sequencing studies (PMID: 28481359), but has not been biochemically characterized and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
E139K missense unknown FOXL2 E139K lies within the DNA binding region of the Foxl2 protein (UniProt.org). E139K has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
E352K missense unknown FOXL2 E352K does not lie within any known functional domains of the Foxl2 protein (UniProt.org). E352K has not been characterized and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
E69D missense unknown FOXL2 E69D lies within the DNA binding region of the Foxl2 protein (UniProt.org). E69D has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
E69K missense unknown FOXL2 E69K lies within the DNA binding region of the Foxl2 protein (UniProt.org). The functional effect of E69K is conflicting as it results in abnormal nuclear aggregation of the Foxl2 protein but also demonstrates transcriptional activity similar to wild-type protein in culture (PMID: 18372316).
E69Q missense unknown FOXL2 E69Q lies within the DNA binding region of the Foxl2 protein (UniProt.org). E69Q has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
F167* nonsense loss of function - predicted FOXL2 F167* results in a premature truncation of the Foxl2 protein at amino acid 167 of 376 (UniProt.org). F167* results in impaired transactivation capacity of Foxl2 in culture in one study (PMID: 19515849) and therefore, is predicted to lead to a loss of Foxl2 protein function.
F90S missense loss of function FOXL2 F90S lies within the DNA binding region of the Foxl2 protein (UniProt.org). F90S results in nuclear and cytoplasmic aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
G121S missense unknown FOXL2 G121S lies within the DNA binding region of the Foxl2 protein (UniProt.org). G121S has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
G38S missense unknown FOXL2 G38S does not lie within any known functional domains of the Foxl2 protein (UniProt.org). G38S has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
G43R missense unknown FOXL2 G43R does not lie within any known functional domains of the Foxl2 protein (UniProt.org). G43R has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
H104N missense no effect - predicted FOXL2 H104N lies within the DNA-binding region of the Foxl2 protein (UniProt.org). H104N demonstrates transactivation capacity similar to wild-type Foxl2 protein in culture in one study (PMID: 19515849) and therefore, is predicted to have no effect on Foxl2 protein function.
H104R missense no effect FOXL2 H104R lies within the DNA-binding region of the Foxl2 protein (UniProt.org). H104R demonstrates cellular localization and transcriptional activity similar to wild-type Foxl2 protein in culture (PMID: 18372316).
I102T missense loss of function FOXL2 I102T lies within the DNA binding region of the Foxl2 protein (UniProt.org). I102T results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
I63fs frameshift loss of function - predicted FOXL2 I63fs results in a change in the amino acid sequence of the Foxl2 protein beginning at aa 63 of 376, likely resulting in a premature truncation of the functional protein (UniProt.org). Due to a loss of the DNA binding domain (UniProt.org), I63fs is predicted to result in a loss of Foxl2 protein function.
I63T missense loss of function FOXL2 I63T lies within the DNA binding region of the Foxl2 protein (UniProt.org). I63T results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
I80T missense loss of function FOXL2 I80T lies within the DNA binding region of the Foxl2 protein (UniProt.org). I80T results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
I84N missense loss of function FOXL2 I84N lies within the DNA binding region of the Foxl2 protein (UniProt.org). I84N results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
I84S missense loss of function FOXL2 I84S lies within the DNA-binding region of the Foxl2 protein (UniProt.org). I84S results in nuclear and cytoplasmic aggregation of the Foxl2 protein and impaired transactivation capacity in culture (PMID: 19515849).
K193S missense unknown FOXL2 K193S does not lie within any known functional domains of the Foxl2 protein (UniProt.org). The functional effect of K193S is conflicting as it results in nuclear aggregation of Foxl2 protein but demonstrates transcriptional activity similar to wild-type protein in culture (PMID: 19515849).
L106F missense loss of function FOXL2 L106F lies within the DNA binding region of the Foxl2 protein (UniProt.org). L106F results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
L106P missense loss of function FOXL2 L106P lies within the DNA binding region of the Foxl2 protein (UniProt.org). L106P results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
L108P missense loss of function - predicted FOXL2 L108P lies within the DNA-binding region of the Foxl2 protein (UniProt.org). L108P results in impaired transactivation capacity of Foxl2 protein in culture in one study (PMID: 19515849) and therefore, is predicted to lead to a loss of Foxl2 protein function.
N105S missense unknown FOXL2 N105S lies within the DNA-binding region of the Foxl2 protein (UniProt.org). The functional effect of N105S is conflicting as it results in abnormal nuclear aggregation of Foxl2 protein but also demonstrates transactivation capacity similar to wild-type protein in culture (PMID: 19515849).
N109K missense unknown FOXL2 N109K lies within the DNA binding region of the Foxl2 protein (UniProt.org). The functional effect of N109K is conflicting as it results in impaired ability to transactivate target genes in culture in one study (PMID: 18372316), but demonstrates transcriptional activity similar to wild-type Foxl2 in another study (PMID: 19515849).
N109S missense unknown FOXL2 N109S lies within the DNA binding region of the Foxl2 protein (UniProt.org). N109S has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
P116Q missense unknown FOXL2 P116Q lies within the DNA binding region of the Foxl2 protein (UniProt.org). P116Q has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
Q219* nonsense loss of function FOXL2 Q219* results in a premature truncation of the Foxl2 protein at amino acid 219 of 376 (UniProt.org). Q219* results in nuclear aggregation and impaired transactivation capacity of Foxl2 protein in culture (PMID: 19515849).
R103C missense unknown FOXL2 R103C lies within the DNA-binding region of the Foxl2 protein (UniProt.org). The functional effect of R103C is conflicting as it results in abnormal nuclear and cytoplasmic aggregation of Foxl2 protein but normal transcriptional activity in one study (PMID: 18372316), and demonstrates impaired transactivation capacity in culture in another study (PMID: 19515849).
R146P missense unknown FOXL2 R146P lies within the DNA binding domain of the Foxl2 protein (UniProt.org). R146P has been identified in sequencing studies (PMID: 22980975), but has not been biochemically characterized and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
R147L missense unknown FOXL2 R147L lies within the DNA binding domain of the Foxl2 protein (UniProt.org). R147L has not been characterized in the scientific literature and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
S101R missense loss of function FOXL2 S101R lies within the DNA binding region of the Foxl2 protein (UniProt.org). S101R results in nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
S217C missense no effect - predicted FOXL2 S217C does not lie within any known functional domains of the Foxl2 protein (UniProt.org). S217C demonstrates transactivation capacity similar to wild-type Foxl2 protein in culture in one study (PMID: 19515849) and therefore, is predicted to have no effect on Foxl2 protein function.
S217F missense gain of function FOXL2 S217F does not lie within any known functional domains of the Foxl2 protein (UniProt.org). S217F results in increased transcriptional activity of Foxl2 protein in culture (PMID: 18372316, PMID: 19515849).
S58L missense loss of function FOXL2 S58L lies within the DNA binding region of the Foxl2 protein (UniProt.org). S58L results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
S70I missense loss of function FOXL2 S70I lies within the DNA binding region of the Foxl2 protein (UniProt.org). S70I results in cytoplasmic aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
T76M missense unknown FOXL2 T76M lies within the DNA binding domain of the Foxl2 protein (UniProt.org). T76M has not been characterized and therefore, its effect on Foxl2 protein function is unknown (PubMed, Aug 2018).
W204* nonsense loss of function FOXL2 W204* results in a premature truncation of the Foxl2 protein at amino acid 204 of 376 (UniProt.org). W204* results in nuclear aggregation and impaired transactivation capacity of Foxl2 protein in culture (PMID: 19515849).
W98G missense loss of function FOXL2 W98G lies within the DNA binding domain of the Foxl2 protein (UniProt.org). W98G results in cytoplasmic and nuclear aggregation of the Foxl2 protein and impaired ability to transactivate target genes in culture (PMID: 18372316).
wild-type none no effect Wild-type FOXL2 indicates that no mutation has been detected within the FOXL2 gene.
Y215C missense unknown FOXL2 Y215C does not lie within any known functional domains of the Foxl2 protein (UniProt.org). The functional effect of Y215C is conflicting as it results in abnormal nuclear aggregation of Foxl2 protein but demonstrates transcriptional activity similar to wild-type protein in culture (PMID: 19515849).